ag-1549 has been researched along with Acquired Immunodeficiency Syndrome in 3 studies
capravirine: a non-nucleoside reverse transcriptase inhibitor
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mowbray, CE | 2 |
| Burt, C | 1 |
| Corbau, R | 2 |
| Gayton, S | 1 |
| Hawes, M | 1 |
| Perros, M | 2 |
| Tran, I | 1 |
| Price, DA | 1 |
| Quinton, FJ | 1 |
| Selby, MD | 1 |
| Stupple, PA | 1 |
| Webster, R | 2 |
| Wood, A | 1 |
| Jones, LH | 1 |
| Allan, G | 1 |
| Hay, D | 1 |
| Middleton, DS | 1 |
| Newman, SD | 1 |
| Randall, A | 1 |
| Vuong, H | 1 |
| Westby, M | 1 |
| Williams, D | 1 |
| Gallant, JE | 1 |
3 other studies available for ag-1549 and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV | 2009 |
Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitors.
Topics: Acquired Immunodeficiency Syndrome; Allosteric Site; Antiviral Agents; Cell Line; Chemistry, Pharmac | 2008 |
New antiretroviral agents.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; | 2001 |